Dr. Henry Li, M.D.
Hematology & Oncology (Hematology & Oncology Physician)
Who else practices at this address →
King County includes primary care (5% of residents) and dental (4% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Stanford University School of Medicine (1996)
- Years since graduation
- 30
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 566
Licensed in Washington since 1998, according to the Washington State Department of Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1996Medical school: Stanford University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
WA license MD00036807 (first issued 1998; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Swedish Medical Center Seattle, WA
- Valley Medical Center Renton, WA
Medical groups
- The Polyclinic PLLC (365 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 566
- Services billed
- 210,318
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, tocilizumab, 1 mg | 49,460 | 30 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 25,500 | 35 |
| Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 7,790 | 20 |
| Injection, golimumab, 1 mg, for intravenous use | 7,050 | 17 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 5,275 | 21 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,165 | 38 |
| Injection, infliximab, excludes biosimilar, 10 mg | 4,140 | 35 |
| Injection, denosumab, 1 mg | 3,660 | 14 |
| Insertion of needle into vein for collection of blood sample | 1,005 | 235 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 978 | 234 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Gabapentin Other prescribers in Seattle, WA | 113 |
| Anastrozole Other prescribers in Seattle, WA | 109 |
| Hydroxyurea Other prescribers in Seattle, WA | 108 |
| Tamoxifen Citrate Other prescribers in Seattle, WA | 71 |
| Calquence (acalabrutinib maleate) | 65 |
| Prednisone Other prescribers in Seattle, WA | 62 |
| Xtandi (enzalutamide) | 61 |
| Letrozole Other prescribers in Seattle, WA | 55 |
| Lorazepam Other prescribers in Seattle, WA | 55 |
| Imatinib Mesylate | 52 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 2 payments worth $128 in total to this clinician.
| Janssen Biotech, Inc. | $99.99 |
|---|---|
| Ars Pharmaceuticals Operations, Inc. | $28.11 |
| Education | $99.99 |
|---|---|
| Food and Beverage | $28.11 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Aug 1, 2025 | Education DARZALEX; TALVEY; TECVAYLI · Oncology · in-kind | $99.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.